Economy & Money
AstraZeneca quarterly net profit rises 2% on strong cancer drug sales
Strong cancer drug sales lifted Anglo-Swedish pharmaceutical giant AstraZeneca’s second-quarter earnings above expectations, helping the company maintain its 2026 outlook.
This story was reported by Business | Euronews RSS. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Business | Euronews RSS →